Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: S&P Capital IQ – STARS Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

St. Jude Medical announces FDA approvals of new pacemakers

Monday, 24 Mar 2014 07:00am EDT 

St. Jude Medical:Approval from U.S. FDA for Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P), which provides additional pacing innovations for physicians to treat patients with heart failure.In addition announced FDA approvals for Assurity pacemaker and Endurity pacemaker families of devices.Quadripolar technology facilitates additional pacing configurations within heart that offer physicians options not available in traditional bipolar systems. 

Company Quote

-0.2 -0.30%
26 Dec 2014